160 related articles for article (PubMed ID: 38192989)
21. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics Analysis of Immune Infiltration In Endometrial Carcinoma Tumors and its Relationship With Prognosis.
Lin Y; Liu S; Bian L; Lin C; Lin P; Teng Z; Hoffman RM; Zhu G; Zhang B
Cancer Diagn Progn; 2023; 3(4):416-427. PubMed ID: 37405226
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
[TBL] [Abstract][Full Text] [Related]
24. Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation.
Zou R; Zheng M; Tan M; Xu H; Luan N; Zhu L
Cancer Manag Res; 2020; 12():5057-5075. PubMed ID: 32617019
[TBL] [Abstract][Full Text] [Related]
25. Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma.
Liu J; Xu M; Wu Z; Yang Y; Yuan S; Liang J; Zhu H
Front Mol Biosci; 2021; 8():670893. PubMed ID: 34095226
[TBL] [Abstract][Full Text] [Related]
26. Up-Frameshift Suppressor 3 as a prognostic biomarker and correlated with immune infiltrates: A pan-cancer analysis.
Xu J; Ma H; Shan B
PLoS One; 2022; 17(10):e0273163. PubMed ID: 36194583
[TBL] [Abstract][Full Text] [Related]
27. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
28. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
29. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer.
Luo Z; Wang Y; Bi X; Ismtula D; Wang H; Guo C
Transl Cancer Res; 2023 Jul; 12(7):1765-1786. PubMed ID: 37588751
[TBL] [Abstract][Full Text] [Related]
31. IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.
Liu C; Zhang W; Zhou X; Liu L
Front Immunol; 2022; 13():983490. PubMed ID: 36618420
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis to Identify
Zhao K; Ma Z; Zhang W
Front Genet; 2021; 12():732822. PubMed ID: 35058964
[No Abstract] [Full Text] [Related]
33. Comprehensive analysis of EML2 as a prognostic biomarker in colon cancer.
Sun Y; Han L; Sun D
Int J Clin Exp Pathol; 2024; 17(1):1-12. PubMed ID: 38322176
[TBL] [Abstract][Full Text] [Related]
34. BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.
Liu J; Tian T; Liu X; Cui Z
J Immunol Res; 2022; 2022():6051092. PubMed ID: 35915658
[TBL] [Abstract][Full Text] [Related]
35. MAIP1-Related Tumor Immune Infiltration: As a Potential Prognostic Biomarker for Esophageal Cancer.
He X; Gan F; Lin Y; Liu G; Lin Y; Chen D
J Immunol Res; 2022; 2022():7282842. PubMed ID: 35747687
[TBL] [Abstract][Full Text] [Related]
36. Identification of
Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
Front Genet; 2022; 13():810292. PubMed ID: 35368661
[TBL] [Abstract][Full Text] [Related]
37. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
38. Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.
Liu L; Xu S; Huang L; He J; Liu G; Ma S; Weng Y; Huang S
Transl Cancer Res; 2021 Jun; 10(6):2859-2872. PubMed ID: 35116596
[TBL] [Abstract][Full Text] [Related]
39. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
40. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]